Premium
Upstream Bio Inc (UPB)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
WALTHAM, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...
WALTHAM, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...
WALTHAM, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...
– Advancing Phase 2 clinical trials of verekitug in patients with severe asthma and CRSwNP – – Commenced startup for a Phase 2 clinical trial in COPD; on track for first patient to be dosed in H2...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -4.24 | -20.7334963325 | 20.45 | 21.13 | 14.97 | 474779 | 18.21329057 | CS |
| 4 | -1.26 | -7.21236405266 | 17.47 | 24.975 | 14.97 | 279076 | 19.82249572 | CS |
| 12 | -5.29 | -24.6046511628 | 21.5 | 29.3 | 14.97 | 321270 | 22.5700444 | CS |
| 26 | -5.29 | -24.6046511628 | 21.5 | 29.3 | 14.97 | 321270 | 22.5700444 | CS |
| 52 | -5.29 | -24.6046511628 | 21.5 | 29.3 | 14.97 | 321270 | 22.5700444 | CS |
| 156 | -5.29 | -24.6046511628 | 21.5 | 29.3 | 14.97 | 321270 | 22.5700444 | CS |
| 260 | -5.29 | -24.6046511628 | 21.5 | 29.3 | 14.97 | 321270 | 22.5700444 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
